← FDA DRUG APPROVALS

FDA NDA · NDA017701

LIDOCAINE HYDROCHLORIDE

Sponsor: INTL MEDICATION

APPLICATION
NDA017701
TYPE
NDA
ORIGINAL APPROVAL
1976-12-03
LATEST ACTION
1986-06-30
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

LIDOCAINE HYDROCHLORIDEDiscontinued
LIDOCAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION
LIDOCAINE HYDROCHLORIDEDiscontinued
LIDOCAINE HYDROCHLORIDE 2% · INJECTABLE · INJECTION

Approval history

1986-06-30Labeling · Supplement 9AP
1986-01-15Labeling · Supplement 8AP
1985-08-23Labeling · Supplement 6AP
1979-07-12Labeling · Supplement 1AP
1976-12-03Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →